Infosys begins to invest afresh in Israel-based Panaya after failed sale bid, plans to hire people in the US
Infosys, in the last three months, appointed a new CEO at Panaya and now looking to hire a slew of people in the US
Currently Panaya's revenue is small because there was a hangover. However, Infosys has not set a goal to grow the business
In January, Infosysdropped plans to sell Panaya and two other subsidiaries Skava and Kallidus after it failed to find potential buyers
A whistleblower report in 2017 had alleged wrongdoings by Infosys and some officials in the $200 million acquisition of Panaya
Months after it failed to sell Panaya, Bengaluru-based Infosys has now reportedly begun to invest in the Israel-based automation software company, a media report said.
According to The Economic Times, in the last three months, Infosys appointed a new CEO at Panaya and is now looking to hire a slew of people in the US. Citing a person familiar with the development, the newspaper said currently Panaya's revenue is small because there was a hangover. However, Infosys has not set a goal to grow the business, the person said.
In January this year, Infosys had dropped plans to sell Panaya and two other subsidiaries Skava and Kallidus after it failed to find any potential buyers.
In April 2018, Infosys had announced its plan to sell Panaya—the Israeli firm whose acquisition became a contentious issue between the founders and the erstwhile management led by Vishal Sikka—along with Kallidus and Skava. Infosys had recognised additional depreciation and amortisation expenses of $12 million and a reduction of $65 million in the carrying value for Skava.
A whistleblower report in 2017 had alleged wrongdoings by Infosys and some officials in the $200 million acquisition of Panaya by the Bengaluru-based IT services firm. In April 20108, the whistleblower had reportedly shot off a letter to market regulator SEBI demanding a probe into the acquisitions of Panaya and Skava.
The whistleblower's letter had questioned board members Ravi Venkatesan, Kiran Mazumdar-Shaw, Punita Sinha and Roopa Kudva, who were all part of the board that approved the Skava and Panaya acquisitions.
However, Infosys’ lead independent director, and the chairperson of Biocon, Kiran Mazumdar-Shaw, had termed the unknown whistleblower's allegations as “unfounded”.
An internal audit committee set up by Infosys found no evidence supporting the whistleblower's allegations.
However, Infosys founder NR Narayana Murthy had demanded that the full report by Gibson, Dunn and Crutcher on these whistleblower allegations be made public.
Later in October 2017, the Infosys board—under its new chairman Nandan Nilekani—gave a clean chit to the controversial Panaya acquisition, saying there was no merit in the allegations of wrongdoing.
It had also said that after a "careful re-consideration" it has concluded that putting out more details of the probe would "inhibit the company's ability to conduct effective investigations into any matter in the future".
With PTI inputs
Sensex rallies over 500 points to reclaim 60,200 level after RBI policy outcome; Nifty up 149 points
Tata Steel was the top gainer in the Sensex pack, rising over 2 percent, followed by Infosys, TCS, Reliance Industries, HCL Tech and Bajaj Auto
According to the Centers for Disease Control and Prevention, Washington will accept travellers who have been jabbed with any of the vaccines approved for emergency use by the World Health Organization, not just those in use in the US
The finance minister said the reforms India has undertaken, particularly the steps taken for the withdrawal of the retrospective tax, have been mentioned by the United States as a very positive step